The global pharmaceutical chemicals market size reached USD 108 billion in 2022 and is projected to hit USD 205.6 billion by the end of 2032, growing at a CAGR of 6.7% during the forecast period 2023 to 2032.
Key Takeaways
- North America led the global market with the highest market share in 2022.
- Asia-Pacific is estimated to expand at the fastest CAGR from 2023 to 2032.
- The basic building blocks segment has held the biggest revenue share in 2022.
- The cardiovascular segment held the highest market share in 2022.
Pharmaceutical chemicals refer to specific type of chemicals that are designed to treat the living cells at definite rick when they enter into environment. Pharmaceutical chemicals are basic chemical components used in the production of pharmaceutical drugs. These chemicals have huge demand across the globe as they deliberated as crucial products in the formation of various drugs. Manufacturing processes of these chemicals are designed to maximize their operating flexibility owing to diversity of modern medicinal chemistry. Changing lifestyle and obesity are responsible for the number of diseases including musculoskeletal diseases, infectious diseases, neurology, respiratory diseases, oncology, gastrointestinal diseases, and diabetes among others. Increasing prevalence of these diseases are creating huge demand for the pharmaceutical chemicals. Most of the pharmaceutical chemicals are used in the food production and various end use applications in the pharma sector.
Get the Sample Pages of Report for More Understanding@ https://www.precedenceresearch.com/sample/1186
Growth Factors:
The global pharmaceutical chemical market is driving due to increasing demand for advanced drugs across the globe. Additionally, constant need of the healthcare facilities, along with increasing old age population worldwide are among major factors to flourish growth of the target industry in the near future. For instance, in Europe the geriatric population aged over 65 found more than 20% in 2019. Growing demand for active pharmaceutical chemicals by the pharmaceutical key players across the globe is expected to augment target industry growth. Furthermore, development of the neurological drugs such as glutamate modulators are supporting to the global industry growth. Changing lifestyle and obesity are leading to increasing various types of chronic diseases which is accelerating the demand for pharmaceutical chemicals.
Moreover, government of developed countries is providing healthcare insurances is having encouraging impact on the growth of global pharmaceutical chemical market. Moreover, increasing government support for innovation especially in the developing countries is another factor to boost growth of the target industry in the near future. Pharmaceutical chemicals are offers various advantages such as less energy consumption as well as cost-effective production which have positive impact on the growth of this industry. Nevertheless, emerging applications of pharmaceutical chemicals is anticipated to create potential opportunities for the growth of the target market.
Regional Analysis:
The report covers data for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America dominated the global market with a market share of more than 35% in 2020. The U.S. registered the highest share in the North American region primarily due to availability of advanced healthcare infrastructure, presence of leading players in the pharmaceutical chemical industry, along with the favorable government policies for the pharmaceutical chemicals production in the region.Further increasing geriatric population and research and development activities by the key companies in the country are other important factors to contribute the high market share of the United States over the forecast period. Further
Europe expected to account for the significant market share in terms of revenue in pharmaceutical chemicals market in the near future. The growth of the pharmaceutical chemicals industry in the countries of the Europe is attributed to growing adoption of the pharmaceutical chemicals in the various end useindustries such as food, cosmetic industries etc. Further, supporting policies for the use of pharmaceutical chemicals by the European government in the region is also projected to increase the demand for pharmaceutical chemicals in the near future. Asia Pacific estimated to grow at the maximum CAGR in the forecast period due increasing demand for chemical pharmaceuticals in the production of active pharmaceutical ingredients such as analgesic drugs, penicillin, vitamins in the countries of the region especially in India, China and Japan of the region.
Report Highlights:
- Among the product segment, basic building blocks segment is dominated the overall market. The advanced intermediates product segment is expected to grow at a significant CAGR during the forecast time-frame. Advanced intermediates encompass the fine and basis chemical.
- Among the application type, cardiovascular segment accounted for the largest revenue with significant share of around 30% in 2020. This is growth is due to increasing prevalence of cardiovascular diseases across the globe. Oncology segment is expected to grow at a significant CAGR during the forecast time-frame.
- BASF segment accounted for a significant share of the global pharmaceutical chemicals market.
Key Market Players and Strategies:
The major companies functioning in the worldwide pharmaceutical chemicals are BASF, Porton Fine Chemicals, Lonza, Johnson Matthey, Dishman, Lanxess, Vertellus Holdings, Jubilant Life Sciences, Hikal, Abbott among others. Noteworthy investment in the research and development of the pharmaceutical chemicals coupled with acquisition, mergers, and strategic collaborations are the key business strategies undertaken by the companies operating in the global pharmaceutical chemicals market.
Market Segmentation
By Product
- Basic building blocks
- Advanced intermediates
- Active ingredients
By Application
- Cardiovascular
- Neurology
- Oncology
- Infectious diseases
- Metabolic system
- Diabetes
- Respiratory diseases
- Gastrointestinal diseases
- Musculoskeletal diseases
- Other
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Table of Content:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Pharmaceutical Chemicals Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Pharmaceutical Chemicals Market
5.1. Covid-19: Pharmaceutical Chemicals Industry Impact
5.2. Pharmaceutical Chemicals Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Pharmaceutical Chemicals Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Pharmaceutical Chemicals Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Pharmaceutical Chemicals Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing generic population
6.1.1.2. Increasing demand for preventive healthcare
6.1.2. Market Restraints
6.1.2.1. Strict environmental standard and high cost of raw materials
6.1.3. Market Opportunities
6.1.3.1. Emerging markets
Chapter 7. Global Pharmaceutical Chemicals Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Pharmaceutical Chemicals Market Revenue by Market Players (2017 - 2020)
7.1.1.2. Pharmaceutical Chemicals Market Revenue Market Share by Market Players (2017 - 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Pharmaceutical Chemicals Market, By Product
8.1. Pharmaceutical Chemicals Market, by Product, 2023-2032
8.1.1. Basic building blocks
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Advanced intermediates
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Active ingredients
8.1.3.1. Market Revenue and Forecast (2021-2032)
Chapter 9. Global Pharmaceutical Chemicals Market, By Application
9.1. Pharmaceutical Chemicals Market, by Application, 2023-2032
9.1.1. Cardiovascular
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Neurology
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.3. Oncology
9.1.3.1. Market Revenue and Forecast (2021-2032)
9.1.4. Infectious diseases
9.1.4.1. Market Revenue and Forecast (2021-2032)
9.1.5. Metabolic system
9.1.5.1. Market Revenue and Forecast (2021-2032)
9.1.6. Diabetes
9.1.6.1. Market Revenue and Forecast (2021-2032)
9.1.7. Respiratory diseases
9.1.7.1. Market Revenue and Forecast (2021-2032)
9.1.8. Gastrointestinal diseases
9.1.8.1. Market Revenue and Forecast (2021-2032)
9.1.9. Musculoskeletal diseases
9.1.9.1. Market Revenue and Forecast (2021-2032)
9.1.10. Other
9.1.10.1. Market Revenue and Forecast (2021-2032)
Chapter 10. Global Pharmaceutical Chemicals Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue Forecast by Product(2021-2032)
10.1.2. Market Revenue Forecast by Application (2021-2032)
10.1.3. U.S
10.1.3.1. Market Revenue Forecast (2021-2032)
10.1.4. Canada
10.1.4.1. Market Revenue Forecast (2021-2032)
10.2. Europe
10.2.1. Market Revenue Forecast by Product (2021-2032)
10.2.2. Market Revenue Forecast by Application (2021-2032)
10.2.3. UK
10.2.3.1. Market Revenue Forecast (2021-2032)
10.2.4. Germany
10.2.4.1. Market Revenue Forecast (2021-2032)
10.2.5. France
10.2.5.1. Market Revenue Forecast (2021-2032)
10.2.6. Rest of EU
10.2.6.1. Market Revenue Forecast (2021-2032)
10.3. Asia Pacific (APAC)
10.3.1. Market Revenue Forecast by Product (2021-2032)
10.3.2. Market Revenue Forecast by Application (2021-2032)
10.3.3. China
10.3.3.1. Market Revenue Forecast (2021-2032)
10.3.4. India
10.3.4.1. Market Revenue Forecast (2021-2032)
10.3.5. Japan
10.3.5.1. Market Revenue Forecast (2021-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue Forecast (2021-2032)
10.4. LATAM
10.4.1. Market Revenue Forecast by Product (2021-2032)
10.4.2. Market Revenue Forecast by Application (2021-2032)
10.4.3. Brazil
10.4.3.1. Market Revenue Forecast (2021-2032)
10.4.4. Rest of LATAM
10.4.4.1. Market Revenue Forecast (2021-2032)
10.5. Middle East and Africa (MEA)
10.5.1. Market Revenue Forecast by Product (2021-2032)
10.5.2. Market Revenue Forecast by Application (2021-2032)
10.5.3. GCC
10.5.3.1. Market Revenue Forecast (2021-2032)
10.5.4. North Africa
10.5.4.1. Market Revenue Forecast (2021-2032)
10.5.5. South Africa
10.5.5.1. Market Revenue Forecast (2021-2032)
10.5.6. Rest of MEA
10.5.6.1. Market Revenue Forecast (2021-2032)
Chapter 11. Company Profiles
11.1. BASF
11.1.1. Company Overview, Business Information, Regional Presence
11.1.2. Product Portfolio Analysis
11.1.2.1. Product Details, Specification, Application
11.1.3. Revenue, Price, and Gross Margin (2017-2020)
11.1.4. Recent Developments and Strategies
11.2. Lonza
11.2.1. Company Overview, Business Information, Regional Presence
11.2.2. Product Portfolio Analysis
11.2.2.1. Product Details, Specification, Application
11.2.3. Revenue, Price, and Gross Margin (2017-2020)
11.2.4. Recent Developments and Strategies
11.3. Porton Fine Chemicals
11.3.1. Company Overview, Business Information, Regional Presence
11.3.2. Product Portfolio Analysis
11.3.2.1. Product Details, Specification, Application
11.3.3. Revenue, Price, and Gross Margin (2017-2020)
11.3.4. Recent Developments and Strategies
11.4. Dishman
11.4.1. Company Overview, Business Information, Regional Presence
11.4.2. Product Portfolio Analysis
11.4.2.1. Product Details, Specification, Application
11.4.3. Revenue, Price, and Gross Margin (2017-2020)
11.4.4. Recent Developments and Strategies
11.5. Lanxess
11.5.1. Company Overview, Business Information, Regional Presence
11.5.2. Product Portfolio Analysis
11.5.2.1. Product Details, Specification, Application
11.5.3. Revenue, Price, and Gross Margin (2017-2020)
11.5.4. Recent Developments and Strategies
11.6. Johnson Matthey
11.6.1. Company Overview, Business Information, Regional Presence
11.6.2. Product Portfolio Analysis
11.6.2.1. Product Details, Specification, Application
11.6.3. Revenue, Price, and Gross Margin (2017-2020)
11.6.4. Recent Developments and Strategies
11.7. Vertellus Holdings
11.7.1. Company Overview, Business Information, Regional Presence
11.7.2. Product Portfolio Analysis
11.7.2.1. Product Details, Specification, Application
11.7.3. Revenue, Price, and Gross Margin (2017-2020)
11.7.4. Recent Developments and Strategies
11.8. Jubilant Life Sciences
11.8.1. Company Overview, Business Information, Regional Presence
11.8.2. Product Portfolio Analysis
11.8.2.1. Product Details, Specification, Application
11.8.3. Revenue, Price, and Gross Margin (2017-2020)
11.8.4. Recent Developments and Strategies
11.9. Hikal
11.9.1. Company Overview, Business Information, Regional Presence
11.9.2. Product Portfolio Analysis
11.9.2.1. Product Details, Specification, Application
11.9.3. Revenue, Price, and Gross Margin (2017-2020)
11.9.4. Recent Developments and Strategies
11.10. Abbott
11.10.1. Company Overview, Business Information, Regional Presence
11.10.2. Product Portfolio Analysis
11.10.2.1. Product Details, Specification, Application
11.10.3. Revenue, Price, and Gross Margin (2017-2020)
11.10.4. Recent Developments and Strategies
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308
About Us
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
0 Comments